Herzinsuffizienz bei Diabetes mellitus | roche.de
Diabetes Patients With CKD Use More Insulin, Even Though Combination Raises Risk of Severe Hypoglycemia - U.S. Medicine
Pharmaceuticals | Free Full-Text | Attenuated Risk Association of End-Stage Kidney Disease with Metformin in Type 2 Diabetes with eGFR Categories 1–4
Epidermal growth factor receptor signaling and the progression of diabetic nephropathy - Koya - 2015 - Journal of Diabetes Investigation - Wiley Online Library
eGFR values in diabetic patients from the five study cohorts | Download Table
Kidney disease progression and all-cause mortality across estimated glomerular filtration rate and albuminuria categories among patients with vs. without type 2 diabetes | BMC Nephrology | Full Text
Pharmacological Management of Glycaemia in People with Type 2 Diabetes and Renal Impairment - GPnotebook Education
Typ-2-Diabetes: Breitere Zulassung für Empagliflozin/Linagliptin
Clinical predictive factors in diabetic kidney disease progression - Radcliffe - 2017 - Journal of Diabetes Investigation - Wiley Online Library
Bei Diabetes regelmäßig eGFR und Albuminausscheidung messen
Testing for kidney disease in type 2 diabetes: consensus statement and recommendations - DiabetesontheNet
Rate of decline in kidney function and known age-of-onset or duration of type 2 diabetes | Scientific Reports
Chronic administration of nano-sized PAMAM dendrimers in vivo inhibits EGFR-ERK1/2-ROCK signaling pathway and attenuates diabetes-induced vascular remodeling and dysfunction - ScienceDirect
Diabetes - edren.org
Neue Leitlinie für das Diabetesmanagement bei chronischer Nierenerkrankung | SpringerLink
Variability in estimated glomerular filtration rate and the incidence of type 2 diabetes: a nationwide population-based study | BMJ Open Diabetes Research & Care
Diabetes und Nierenerkrankung: Prävention und Therapie | Diabetes Forum
Decline of estimated glomerular filtration rate (eGFR) in all patients... | Download Scientific Diagram
Heritability of renal function decline measured by the rate of eGFR loss in type 1 diabetes - Media Centre | EASD
Frontiers | Epidermal Growth Factor Receptor: A Potential Therapeutic Target for Diabetic Kidney Disease
Pharmacotherapeutic Options for Type 2 Diabetes Patients Stratified by eGFR | Radcliffe Cardiology
